Abstract Background Coronavirus disease 2019 (COVID-19) is frequntly accompanied by
venous thromboembolism (VTE), and its mechanism may be related to the abnormal …

Venous thromboembolism is prevalent in hospitalized COVID-19 patients. Through
systematic review and meta-analysis, we have investigated the differences in clinical …

Abstract Purpose Coronavirus disease‐2019 (COVID‐19) may predispose to venous
thromboembolism (VTE) and arterial thromboembolism because of excessive inflammation …

Venous thromboembolism (VTE) in patients with COVID-19 in intensive care units (ICU) is
frequent, but risk factors (RF) remain unidentified. In this meta-analysis (CRD42020188764) …

Background: Thrombosis is a characteristic complication in coronavirus disease 2019
(COVID-19). Since coagulopathy has been observed over the entire clinical course …

Background Venous thromboembolism (VTE) is frequently observed in patients with
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …

SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection is associated with
high risk of venous and arterial thrombosis. Thrombotic complications, especially pulmonary …

Introduction: Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection resulting in COVID-19 disease is associated with widespread inflammation and a …

Background: A high incidence of venous thromboembolism (VTE) is reported in hospitalized
COVID-19 patients, in particular in patients admitted to the intensive care unit (ICU). In …

Abstract Coronavirus disease 2019 (COVID-19) has affected more than 6 million patients
worldwide. Deep venous thrombosis (DVT) has been increasingly recognized complication …